XTRA:FMEHealthcare
Assessing Fresenius Medical Care (XTRA:FME) Valuation After Earnings Jump Dividend Hike And Buyback Completion
Why Fresenius Medical Care is back on investors’ radar
Fresenius Medical Care (XTRA:FME) has just packed several key updates into its 2025 results, including a sharp rise in net income, higher earnings per share, new 2026 guidance, a higher proposed dividend, and completion of a sizeable buyback.
See our latest analysis for Fresenius Medical Care.
These 2025 results, new 2026 guidance and the completed buyback come after a mixed stretch for the stock, with a 30 day share price return of 4.22%...